Nasal pharmaceutical formulations and methods of using the same

Details for Australian Patent Application No. 2004229147 (hide)

International Classifications

Event Publications

8 December 2005 PCT application entered the National Phase

PCT publication WO2004/091574 Priority application(s): WO2004/091574

21 September 2006 Amendment Made

The nature of the amendment is: Amend the priority details to read 10/414,756 16 Apr 2003 US 2004229148 Merck Patent GmbH The nature of the amendment is: Amend the priority details to read 10/414,682 16 Apr 2003 US 2004242426 Opdetech Pty Ltd The nature of the amendment is: Add co-inventor McCoy, Donald George

12 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.